nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—ABCC2—Vinblastine—head and neck cancer	0.118	0.179	CbGbCtD
Carbamazepine—ABCC2—Docetaxel—head and neck cancer	0.097	0.148	CbGbCtD
Carbamazepine—CYP3A7—Docetaxel—head and neck cancer	0.0648	0.0988	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0648	0.0988	CbGbCtD
Carbamazepine—CYP2C8—Fluorouracil—head and neck cancer	0.0612	0.0933	CbGbCtD
Carbamazepine—CYP3A5—Docetaxel—head and neck cancer	0.0486	0.0741	CbGbCtD
Carbamazepine—CYP1A2—Fluorouracil—head and neck cancer	0.0474	0.0722	CbGbCtD
Carbamazepine—CYP2C9—Fluorouracil—head and neck cancer	0.0427	0.0651	CbGbCtD
Carbamazepine—ABCB1—Vinblastine—head and neck cancer	0.0384	0.0585	CbGbCtD
Carbamazepine—ABCB1—Docetaxel—head and neck cancer	0.0316	0.0482	CbGbCtD
Carbamazepine—CYP3A4—Vinblastine—head and neck cancer	0.023	0.035	CbGbCtD
Carbamazepine—CYP3A4—Docetaxel—head and neck cancer	0.0189	0.0289	CbGbCtD
Carbamazepine—Dermatitis atopic—Docetaxel—head and neck cancer	0.00117	0.00415	CcSEcCtD
Carbamazepine—Neuritis—Docetaxel—head and neck cancer	0.00116	0.00412	CcSEcCtD
Carbamazepine—Coma—Fluorouracil—head and neck cancer	0.0011	0.00389	CcSEcCtD
Carbamazepine—Pancytopenia—Vinblastine—head and neck cancer	0.00109	0.00386	CcSEcCtD
Carbamazepine—Nepafenac—PTGS2—head and neck cancer	0.00106	0.275	CrCbGaD
Carbamazepine—Magnesium salicylate—PTGS2—head and neck cancer	0.00103	0.269	CrCbGaD
Carbamazepine—Pancreatitis—Hydroxyurea—head and neck cancer	0.00103	0.00364	CcSEcCtD
Carbamazepine—Depression—Vinblastine—head and neck cancer	0.00102	0.00362	CcSEcCtD
Carbamazepine—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00101	0.00357	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00101	0.00356	CcSEcCtD
Carbamazepine—Pancytopenia—Hydroxyurea—head and neck cancer	0.000996	0.00352	CcSEcCtD
Carbamazepine—Photosensitivity—Fluorouracil—head and neck cancer	0.000995	0.00352	CcSEcCtD
Carbamazepine—Swelling—Fluorouracil—head and neck cancer	0.00099	0.0035	CcSEcCtD
Carbamazepine—Disorientation—Fluorouracil—head and neck cancer	0.000976	0.00345	CcSEcCtD
Carbamazepine—Bone disorder—Docetaxel—head and neck cancer	0.000961	0.0034	CcSEcCtD
Carbamazepine—Agranulocytosis—Vinblastine—head and neck cancer	0.000957	0.00339	CcSEcCtD
Carbamazepine—Weight increased—Hydroxyurea—head and neck cancer	0.000954	0.00338	CcSEcCtD
Carbamazepine—Oliguria—Docetaxel—head and neck cancer	0.000942	0.00333	CcSEcCtD
Carbamazepine—Drug interaction—Docetaxel—head and neck cancer	0.000936	0.00331	CcSEcCtD
Carbamazepine—Infestation NOS—Hydroxyurea—head and neck cancer	0.000935	0.00331	CcSEcCtD
Carbamazepine—Drowsiness—Hydroxyurea—head and neck cancer	0.000935	0.00331	CcSEcCtD
Carbamazepine—Infestation—Hydroxyurea—head and neck cancer	0.000935	0.00331	CcSEcCtD
Carbamazepine—Amnesia—Fluorouracil—head and neck cancer	0.00093	0.00329	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000917	0.00324	CcSEcCtD
Carbamazepine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000914	0.00323	CcSEcCtD
Carbamazepine—Pharyngitis—Vinblastine—head and neck cancer	0.000914	0.00323	CcSEcCtD
Carbamazepine—Hearing impaired—Docetaxel—head and neck cancer	0.000912	0.00323	CcSEcCtD
Carbamazepine—Stomatitis—Hydroxyurea—head and neck cancer	0.000911	0.00323	CcSEcCtD
Carbamazepine—Cardiac failure—Fluorouracil—head and neck cancer	0.000895	0.00317	CcSEcCtD
Carbamazepine—Lethargy—Fluorouracil—head and neck cancer	0.000891	0.00315	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000884	0.00313	CcSEcCtD
Carbamazepine—Salsalate—PTGS2—head and neck cancer	0.000877	0.228	CrCbGaD
Carbamazepine—Oxaprozin—PTGS2—head and neck cancer	0.000877	0.228	CrCbGaD
Carbamazepine—Osteoarthritis—Fluorouracil—head and neck cancer	0.000873	0.00309	CcSEcCtD
Carbamazepine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000868	0.00307	CcSEcCtD
Carbamazepine—Pulmonary embolism—Docetaxel—head and neck cancer	0.000868	0.00307	CcSEcCtD
Carbamazepine—Blood pressure increased—Docetaxel—head and neck cancer	0.000868	0.00307	CcSEcCtD
Carbamazepine—Hallucination—Hydroxyurea—head and neck cancer	0.000835	0.00296	CcSEcCtD
Carbamazepine—Colitis—Docetaxel—head and neck cancer	0.000834	0.00295	CcSEcCtD
Carbamazepine—Irritability—Fluorouracil—head and neck cancer	0.000834	0.00295	CcSEcCtD
Carbamazepine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00083	0.00294	CcSEcCtD
Carbamazepine—Fluid retention—Docetaxel—head and neck cancer	0.000824	0.00292	CcSEcCtD
Carbamazepine—Ataxia—Fluorouracil—head and neck cancer	0.000821	0.00291	CcSEcCtD
Carbamazepine—Alopecia—Vinblastine—head and neck cancer	0.000813	0.00288	CcSEcCtD
Carbamazepine—Pulmonary oedema—Docetaxel—head and neck cancer	0.000773	0.00274	CcSEcCtD
Carbamazepine—Muscular weakness—Fluorouracil—head and neck cancer	0.00077	0.00273	CcSEcCtD
Carbamazepine—Angiopathy—Hydroxyurea—head and neck cancer	0.000762	0.00269	CcSEcCtD
Carbamazepine—Dysphagia—Fluorouracil—head and neck cancer	0.000755	0.00267	CcSEcCtD
Carbamazepine—Chills—Hydroxyurea—head and neck cancer	0.000753	0.00267	CcSEcCtD
Carbamazepine—Eosinophilia—Fluorouracil—head and neck cancer	0.000747	0.00264	CcSEcCtD
Carbamazepine—Alopecia—Hydroxyurea—head and neck cancer	0.000742	0.00262	CcSEcCtD
Carbamazepine—Anaemia—Vinblastine—head and neck cancer	0.000741	0.00262	CcSEcCtD
Carbamazepine—Erythema—Hydroxyurea—head and neck cancer	0.000731	0.00259	CcSEcCtD
Carbamazepine—Thrombophlebitis—Docetaxel—head and neck cancer	0.000728	0.00258	CcSEcCtD
Carbamazepine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000725	0.00256	CcSEcCtD
Carbamazepine—Vertigo—Vinblastine—head and neck cancer	0.00072	0.00255	CcSEcCtD
Carbamazepine—Leukopenia—Vinblastine—head and neck cancer	0.000717	0.00254	CcSEcCtD
Carbamazepine—Pancytopenia—Fluorouracil—head and neck cancer	0.000717	0.00254	CcSEcCtD
Carbamazepine—Swelling—Docetaxel—head and neck cancer	0.000715	0.00253	CcSEcCtD
Carbamazepine—Deafness—Docetaxel—head and neck cancer	0.000705	0.00249	CcSEcCtD
Carbamazepine—Hepatic failure—Docetaxel—head and neck cancer	0.000701	0.00248	CcSEcCtD
Carbamazepine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000695	0.00246	CcSEcCtD
Carbamazepine—Convulsion—Vinblastine—head and neck cancer	0.000694	0.00246	CcSEcCtD
Carbamazepine—Hypertension—Vinblastine—head and neck cancer	0.000692	0.00245	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000689	0.00244	CcSEcCtD
Carbamazepine—Pneumonia—Fluorouracil—head and neck cancer	0.000677	0.0024	CcSEcCtD
Carbamazepine—Anaemia—Hydroxyurea—head and neck cancer	0.000675	0.00239	CcSEcCtD
Carbamazepine—Infestation NOS—Fluorouracil—head and neck cancer	0.000673	0.00238	CcSEcCtD
Carbamazepine—Infestation—Fluorouracil—head and neck cancer	0.000673	0.00238	CcSEcCtD
Carbamazepine—Renal impairment—Docetaxel—head and neck cancer	0.000662	0.00234	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00066	0.00233	CcSEcCtD
Carbamazepine—Dermatitis bullous—Docetaxel—head and neck cancer	0.00066	0.00233	CcSEcCtD
Carbamazepine—Stomatitis—Fluorouracil—head and neck cancer	0.000656	0.00232	CcSEcCtD
Carbamazepine—Urinary tract infection—Fluorouracil—head and neck cancer	0.000654	0.00231	CcSEcCtD
Carbamazepine—Conjunctivitis—Fluorouracil—head and neck cancer	0.000654	0.00231	CcSEcCtD
Carbamazepine—Leukopenia—Hydroxyurea—head and neck cancer	0.000654	0.00231	CcSEcCtD
Carbamazepine—Cardiac failure—Docetaxel—head and neck cancer	0.000646	0.00229	CcSEcCtD
Carbamazepine—Lethargy—Docetaxel—head and neck cancer	0.000643	0.00228	CcSEcCtD
Carbamazepine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00064	0.00227	CcSEcCtD
Carbamazepine—Convulsion—Hydroxyurea—head and neck cancer	0.000633	0.00224	CcSEcCtD
Carbamazepine—Hyponatraemia—Docetaxel—head and neck cancer	0.000633	0.00224	CcSEcCtD
Carbamazepine—Sinusitis—Fluorouracil—head and neck cancer	0.000631	0.00223	CcSEcCtD
Carbamazepine—Agranulocytosis—Fluorouracil—head and neck cancer	0.000628	0.00222	CcSEcCtD
Carbamazepine—Anorexia—Vinblastine—head and neck cancer	0.000623	0.00221	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000618	0.00219	CcSEcCtD
Carbamazepine—Rhinitis—Fluorouracil—head and neck cancer	0.000606	0.00214	CcSEcCtD
Carbamazepine—Pharyngitis—Fluorouracil—head and neck cancer	0.0006	0.00212	CcSEcCtD
Carbamazepine—Oedema—Hydroxyurea—head and neck cancer	0.000596	0.00211	CcSEcCtD
Carbamazepine—Ataxia—Docetaxel—head and neck cancer	0.000593	0.0021	CcSEcCtD
Carbamazepine—Infection—Hydroxyurea—head and neck cancer	0.000592	0.0021	CcSEcCtD
Carbamazepine—Paraesthesia—Vinblastine—head and neck cancer	0.000587	0.00208	CcSEcCtD
Carbamazepine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000585	0.00207	CcSEcCtD
Carbamazepine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000584	0.00207	CcSEcCtD
Carbamazepine—Liver function test abnormal—Docetaxel—head and neck cancer	0.000582	0.00206	CcSEcCtD
Carbamazepine—Skin disorder—Hydroxyurea—head and neck cancer	0.000579	0.00205	CcSEcCtD
Carbamazepine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000576	0.00204	CcSEcCtD
Carbamazepine—Anorexia—Hydroxyurea—head and neck cancer	0.000568	0.00201	CcSEcCtD
Carbamazepine—Decreased appetite—Vinblastine—head and neck cancer	0.000568	0.00201	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000568	0.00201	CcSEcCtD
Carbamazepine—Cramp muscle—Docetaxel—head and neck cancer	0.000568	0.00201	CcSEcCtD
Carbamazepine—Pain—Vinblastine—head and neck cancer	0.000559	0.00198	CcSEcCtD
Carbamazepine—Constipation—Vinblastine—head and neck cancer	0.000559	0.00198	CcSEcCtD
Carbamazepine—Dysphagia—Docetaxel—head and neck cancer	0.000545	0.00193	CcSEcCtD
Carbamazepine—Arrhythmia—Fluorouracil—head and neck cancer	0.00054	0.00191	CcSEcCtD
Carbamazepine—Feeling abnormal—Vinblastine—head and neck cancer	0.000539	0.00191	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000535	0.00189	CcSEcCtD
Carbamazepine—Alopecia—Fluorouracil—head and neck cancer	0.000534	0.00189	CcSEcCtD
Carbamazepine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000532	0.00188	CcSEcCtD
Carbamazepine—Somnolence—Hydroxyurea—head and neck cancer	0.00053	0.00188	CcSEcCtD
Carbamazepine—Erythema—Fluorouracil—head and neck cancer	0.000526	0.00186	CcSEcCtD
Carbamazepine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000525	0.00186	CcSEcCtD
Carbamazepine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000518	0.00183	CcSEcCtD
Carbamazepine—Pancytopenia—Docetaxel—head and neck cancer	0.000517	0.00183	CcSEcCtD
Carbamazepine—Abdominal pain—Vinblastine—head and neck cancer	0.000517	0.00183	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000515	0.00182	CcSEcCtD
Carbamazepine—Fatigue—Hydroxyurea—head and neck cancer	0.000514	0.00182	CcSEcCtD
Carbamazepine—Pain—Hydroxyurea—head and neck cancer	0.00051	0.0018	CcSEcCtD
Carbamazepine—Constipation—Hydroxyurea—head and neck cancer	0.00051	0.0018	CcSEcCtD
Carbamazepine—Weight increased—Docetaxel—head and neck cancer	0.000496	0.00175	CcSEcCtD
Carbamazepine—Vision blurred—Fluorouracil—head and neck cancer	0.000496	0.00175	CcSEcCtD
Carbamazepine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000491	0.00174	CcSEcCtD
Carbamazepine—Pneumonia—Docetaxel—head and neck cancer	0.000489	0.00173	CcSEcCtD
Carbamazepine—Anaemia—Fluorouracil—head and neck cancer	0.000486	0.00172	CcSEcCtD
Carbamazepine—Infestation—Docetaxel—head and neck cancer	0.000486	0.00172	CcSEcCtD
Carbamazepine—Infestation NOS—Docetaxel—head and neck cancer	0.000486	0.00172	CcSEcCtD
Carbamazepine—Hypersensitivity—Vinblastine—head and neck cancer	0.000482	0.0017	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000482	0.0017	CcSEcCtD
Carbamazepine—Renal failure—Docetaxel—head and neck cancer	0.000478	0.00169	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000476	0.00168	CcSEcCtD
Carbamazepine—Jaundice—Docetaxel—head and neck cancer	0.000473	0.00168	CcSEcCtD
Carbamazepine—Stomatitis—Docetaxel—head and neck cancer	0.000473	0.00168	CcSEcCtD
Carbamazepine—Conjunctivitis—Docetaxel—head and neck cancer	0.000472	0.00167	CcSEcCtD
Carbamazepine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000471	0.00167	CcSEcCtD
Carbamazepine—Leukopenia—Fluorouracil—head and neck cancer	0.000471	0.00167	CcSEcCtD
Carbamazepine—Asthenia—Vinblastine—head and neck cancer	0.000469	0.00166	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000459	0.00163	CcSEcCtD
Carbamazepine—Convulsion—Fluorouracil—head and neck cancer	0.000456	0.00161	CcSEcCtD
Carbamazepine—Agranulocytosis—Docetaxel—head and neck cancer	0.000453	0.0016	CcSEcCtD
Carbamazepine—Chest pain—Fluorouracil—head and neck cancer	0.000448	0.00158	CcSEcCtD
Carbamazepine—Myalgia—Fluorouracil—head and neck cancer	0.000448	0.00158	CcSEcCtD
Carbamazepine—Diarrhoea—Vinblastine—head and neck cancer	0.000447	0.00158	CcSEcCtD
Carbamazepine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000439	0.00155	CcSEcCtD
Carbamazepine—Rhinitis—Docetaxel—head and neck cancer	0.000437	0.00155	CcSEcCtD
Carbamazepine—Hepatitis—Docetaxel—head and neck cancer	0.000436	0.00154	CcSEcCtD
Carbamazepine—Confusional state—Fluorouracil—head and neck cancer	0.000433	0.00153	CcSEcCtD
Carbamazepine—Pharyngitis—Docetaxel—head and neck cancer	0.000433	0.00153	CcSEcCtD
Carbamazepine—Dizziness—Vinblastine—head and neck cancer	0.000432	0.00153	CcSEcCtD
Carbamazepine—Urinary tract disorder—Docetaxel—head and neck cancer	0.000431	0.00152	CcSEcCtD
Carbamazepine—Oedema peripheral—Docetaxel—head and neck cancer	0.00043	0.00152	CcSEcCtD
Carbamazepine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000429	0.00152	CcSEcCtD
Carbamazepine—Oedema—Fluorouracil—head and neck cancer	0.000429	0.00152	CcSEcCtD
Carbamazepine—Connective tissue disorder—Docetaxel—head and neck cancer	0.000429	0.00152	CcSEcCtD
Carbamazepine—Asthenia—Hydroxyurea—head and neck cancer	0.000428	0.00151	CcSEcCtD
Carbamazepine—Urethral disorder—Docetaxel—head and neck cancer	0.000427	0.00151	CcSEcCtD
Carbamazepine—Infection—Fluorouracil—head and neck cancer	0.000426	0.00151	CcSEcCtD
Carbamazepine—Nervous system disorder—Fluorouracil—head and neck cancer	0.000421	0.00149	CcSEcCtD
Carbamazepine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00042	0.00149	CcSEcCtD
Carbamazepine—Tachycardia—Fluorouracil—head and neck cancer	0.000419	0.00148	CcSEcCtD
Carbamazepine—Vomiting—Vinblastine—head and neck cancer	0.000416	0.00147	CcSEcCtD
Carbamazepine—Erythema multiforme—Docetaxel—head and neck cancer	0.000412	0.00146	CcSEcCtD
Carbamazepine—Headache—Vinblastine—head and neck cancer	0.00041	0.00145	CcSEcCtD
Carbamazepine—Anorexia—Fluorouracil—head and neck cancer	0.000409	0.00145	CcSEcCtD
Carbamazepine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000408	0.00144	CcSEcCtD
Carbamazepine—Eye disorder—Docetaxel—head and neck cancer	0.000408	0.00144	CcSEcCtD
Carbamazepine—Flushing—Docetaxel—head and neck cancer	0.000405	0.00143	CcSEcCtD
Carbamazepine—Cardiac disorder—Docetaxel—head and neck cancer	0.000405	0.00143	CcSEcCtD
Carbamazepine—Hypotension—Fluorouracil—head and neck cancer	0.000401	0.00142	CcSEcCtD
Carbamazepine—Angiopathy—Docetaxel—head and neck cancer	0.000396	0.0014	CcSEcCtD
Carbamazepine—Dizziness—Hydroxyurea—head and neck cancer	0.000394	0.0014	CcSEcCtD
Carbamazepine—Immune system disorder—Docetaxel—head and neck cancer	0.000394	0.00139	CcSEcCtD
Carbamazepine—Mediastinal disorder—Docetaxel—head and neck cancer	0.000393	0.00139	CcSEcCtD
Carbamazepine—Chills—Docetaxel—head and neck cancer	0.000391	0.00138	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000391	0.00138	CcSEcCtD
Carbamazepine—Arrhythmia—Docetaxel—head and neck cancer	0.00039	0.00138	CcSEcCtD
Carbamazepine—Nausea—Vinblastine—head and neck cancer	0.000388	0.00137	CcSEcCtD
Carbamazepine—Insomnia—Fluorouracil—head and neck cancer	0.000388	0.00137	CcSEcCtD
Carbamazepine—Paraesthesia—Fluorouracil—head and neck cancer	0.000385	0.00136	CcSEcCtD
Carbamazepine—Alopecia—Docetaxel—head and neck cancer	0.000385	0.00136	CcSEcCtD
Carbamazepine—Dyspnoea—Fluorouracil—head and neck cancer	0.000383	0.00135	CcSEcCtD
Carbamazepine—Mental disorder—Docetaxel—head and neck cancer	0.000382	0.00135	CcSEcCtD
Carbamazepine—Somnolence—Fluorouracil—head and neck cancer	0.000382	0.00135	CcSEcCtD
Carbamazepine—Erythema—Docetaxel—head and neck cancer	0.00038	0.00134	CcSEcCtD
Carbamazepine—Malnutrition—Docetaxel—head and neck cancer	0.00038	0.00134	CcSEcCtD
Carbamazepine—Vomiting—Hydroxyurea—head and neck cancer	0.000379	0.00134	CcSEcCtD
Carbamazepine—Dyspepsia—Fluorouracil—head and neck cancer	0.000378	0.00134	CcSEcCtD
Carbamazepine—Rash—Hydroxyurea—head and neck cancer	0.000376	0.00133	CcSEcCtD
Carbamazepine—Dermatitis—Hydroxyurea—head and neck cancer	0.000376	0.00133	CcSEcCtD
Carbamazepine—Headache—Hydroxyurea—head and neck cancer	0.000374	0.00132	CcSEcCtD
Carbamazepine—Decreased appetite—Fluorouracil—head and neck cancer	0.000373	0.00132	CcSEcCtD
Carbamazepine—Dysgeusia—Docetaxel—head and neck cancer	0.000372	0.00132	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000371	0.00131	CcSEcCtD
Carbamazepine—Back pain—Docetaxel—head and neck cancer	0.000367	0.0013	CcSEcCtD
Carbamazepine—Pain—Fluorouracil—head and neck cancer	0.000367	0.0013	CcSEcCtD
Carbamazepine—Muscle spasms—Docetaxel—head and neck cancer	0.000365	0.00129	CcSEcCtD
Carbamazepine—Nausea—Hydroxyurea—head and neck cancer	0.000354	0.00125	CcSEcCtD
Carbamazepine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000354	0.00125	CcSEcCtD
Carbamazepine—Anaemia—Docetaxel—head and neck cancer	0.000351	0.00124	CcSEcCtD
Carbamazepine—Urticaria—Fluorouracil—head and neck cancer	0.000341	0.00121	CcSEcCtD
Carbamazepine—Syncope—Docetaxel—head and neck cancer	0.00034	0.0012	CcSEcCtD
Carbamazepine—Leukopenia—Docetaxel—head and neck cancer	0.00034	0.0012	CcSEcCtD
Carbamazepine—Body temperature increased—Fluorouracil—head and neck cancer	0.000339	0.0012	CcSEcCtD
Carbamazepine—Loss of consciousness—Docetaxel—head and neck cancer	0.000334	0.00118	CcSEcCtD
Carbamazepine—Convulsion—Docetaxel—head and neck cancer	0.000329	0.00116	CcSEcCtD
Carbamazepine—Hypertension—Docetaxel—head and neck cancer	0.000328	0.00116	CcSEcCtD
Carbamazepine—Arthralgia—Docetaxel—head and neck cancer	0.000323	0.00114	CcSEcCtD
Carbamazepine—Chest pain—Docetaxel—head and neck cancer	0.000323	0.00114	CcSEcCtD
Carbamazepine—Myalgia—Docetaxel—head and neck cancer	0.000323	0.00114	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000321	0.00114	CcSEcCtD
Carbamazepine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000316	0.00112	CcSEcCtD
Carbamazepine—Dry mouth—Docetaxel—head and neck cancer	0.000316	0.00112	CcSEcCtD
Carbamazepine—Confusional state—Docetaxel—head and neck cancer	0.000312	0.00111	CcSEcCtD
Carbamazepine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00031	0.0011	CcSEcCtD
Carbamazepine—Oedema—Docetaxel—head and neck cancer	0.00031	0.0011	CcSEcCtD
Carbamazepine—Infection—Docetaxel—head and neck cancer	0.000308	0.00109	CcSEcCtD
Carbamazepine—Shock—Docetaxel—head and neck cancer	0.000305	0.00108	CcSEcCtD
Carbamazepine—Nervous system disorder—Docetaxel—head and neck cancer	0.000304	0.00108	CcSEcCtD
Carbamazepine—Pruritus—Fluorouracil—head and neck cancer	0.000304	0.00107	CcSEcCtD
Carbamazepine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000303	0.00107	CcSEcCtD
Carbamazepine—Tachycardia—Docetaxel—head and neck cancer	0.000302	0.00107	CcSEcCtD
Carbamazepine—Skin disorder—Docetaxel—head and neck cancer	0.000301	0.00106	CcSEcCtD
Carbamazepine—Anorexia—Docetaxel—head and neck cancer	0.000295	0.00105	CcSEcCtD
Carbamazepine—Diarrhoea—Fluorouracil—head and neck cancer	0.000294	0.00104	CcSEcCtD
Carbamazepine—Hypotension—Docetaxel—head and neck cancer	0.000289	0.00102	CcSEcCtD
Carbamazepine—Dizziness—Fluorouracil—head and neck cancer	0.000284	0.001	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000282	0.000999	CcSEcCtD
Carbamazepine—Insomnia—Docetaxel—head and neck cancer	0.00028	0.000992	CcSEcCtD
Carbamazepine—Paraesthesia—Docetaxel—head and neck cancer	0.000278	0.000984	CcSEcCtD
Carbamazepine—Dyspnoea—Docetaxel—head and neck cancer	0.000276	0.000977	CcSEcCtD
Carbamazepine—Somnolence—Docetaxel—head and neck cancer	0.000275	0.000975	CcSEcCtD
Carbamazepine—Vomiting—Fluorouracil—head and neck cancer	0.000273	0.000966	CcSEcCtD
Carbamazepine—Dyspepsia—Docetaxel—head and neck cancer	0.000273	0.000965	CcSEcCtD
Carbamazepine—Rash—Fluorouracil—head and neck cancer	0.000271	0.000958	CcSEcCtD
Carbamazepine—Dermatitis—Fluorouracil—head and neck cancer	0.00027	0.000957	CcSEcCtD
Carbamazepine—Decreased appetite—Docetaxel—head and neck cancer	0.000269	0.000953	CcSEcCtD
Carbamazepine—Headache—Fluorouracil—head and neck cancer	0.000269	0.000952	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000267	0.000946	CcSEcCtD
Carbamazepine—Fatigue—Docetaxel—head and neck cancer	0.000267	0.000945	CcSEcCtD
Carbamazepine—Constipation—Docetaxel—head and neck cancer	0.000265	0.000937	CcSEcCtD
Carbamazepine—Pain—Docetaxel—head and neck cancer	0.000265	0.000937	CcSEcCtD
Carbamazepine—Feeling abnormal—Docetaxel—head and neck cancer	0.000255	0.000903	CcSEcCtD
Carbamazepine—Nausea—Fluorouracil—head and neck cancer	0.000255	0.000902	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000253	0.000896	CcSEcCtD
Carbamazepine—Abdominal pain—Docetaxel—head and neck cancer	0.000245	0.000867	CcSEcCtD
Carbamazepine—Body temperature increased—Docetaxel—head and neck cancer	0.000245	0.000867	CcSEcCtD
Carbamazepine—Hypersensitivity—Docetaxel—head and neck cancer	0.000228	0.000808	CcSEcCtD
Carbamazepine—Asthenia—Docetaxel—head and neck cancer	0.000222	0.000787	CcSEcCtD
Carbamazepine—Pruritus—Docetaxel—head and neck cancer	0.000219	0.000776	CcSEcCtD
Carbamazepine—Diarrhoea—Docetaxel—head and neck cancer	0.000212	0.00075	CcSEcCtD
Carbamazepine—Dizziness—Docetaxel—head and neck cancer	0.000205	0.000725	CcSEcCtD
Carbamazepine—Vomiting—Docetaxel—head and neck cancer	0.000197	0.000697	CcSEcCtD
Carbamazepine—Rash—Docetaxel—head and neck cancer	0.000195	0.000691	CcSEcCtD
Carbamazepine—Dermatitis—Docetaxel—head and neck cancer	0.000195	0.000691	CcSEcCtD
Carbamazepine—Headache—Docetaxel—head and neck cancer	0.000194	0.000687	CcSEcCtD
Carbamazepine—Nausea—Docetaxel—head and neck cancer	0.000184	0.000651	CcSEcCtD
Carbamazepine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000103	0.00178	CbGpPWpGaD
Carbamazepine—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000103	0.00178	CbGpPWpGaD
Carbamazepine—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000102	0.00176	CbGpPWpGaD
Carbamazepine—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.0001	0.00174	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—VEGFA—head and neck cancer	9.98e-05	0.00173	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	9.92e-05	0.00172	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—CASP8—head and neck cancer	9.89e-05	0.00171	CbGpPWpGaD
Carbamazepine—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	9.86e-05	0.00171	CbGpPWpGaD
Carbamazepine—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	9.73e-05	0.00169	CbGpPWpGaD
Carbamazepine—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	9.64e-05	0.00167	CbGpPWpGaD
Carbamazepine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	9.57e-05	0.00166	CbGpPWpGaD
Carbamazepine—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	9.51e-05	0.00165	CbGpPWpGaD
Carbamazepine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	9.44e-05	0.00164	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—MAPK3—head and neck cancer	9.44e-05	0.00163	CbGpPWpGaD
Carbamazepine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.28e-05	0.00161	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	9.2e-05	0.00159	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—VEGFA—head and neck cancer	9.17e-05	0.00159	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—MAPK1—head and neck cancer	8.98e-05	0.00156	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—EGFR—head and neck cancer	8.98e-05	0.00155	CbGpPWpGaD
Carbamazepine—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	8.81e-05	0.00153	CbGpPWpGaD
Carbamazepine—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	8.69e-05	0.00151	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—UROD—head and neck cancer	8.68e-05	0.0015	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—MAPK3—head and neck cancer	8.67e-05	0.0015	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—UROD—head and neck cancer	8.48e-05	0.00147	CbGpPWpGaD
Carbamazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.44e-05	0.00146	CbGpPWpGaD
Carbamazepine—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	8.35e-05	0.00145	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—MAPK1—head and neck cancer	8.25e-05	0.00143	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—EGFR—head and neck cancer	8.25e-05	0.00143	CbGpPWpGaD
Carbamazepine—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	8.24e-05	0.00143	CbGpPWpGaD
Carbamazepine—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	7.86e-05	0.00136	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	7.81e-05	0.00135	CbGpPWpGaD
Carbamazepine—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	7.76e-05	0.00134	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—NOTCH1—head and neck cancer	7.58e-05	0.00131	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—IL2—head and neck cancer	7.47e-05	0.00129	CbGpPWpGaD
Carbamazepine—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	7.45e-05	0.00129	CbGpPWpGaD
Carbamazepine—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	7.35e-05	0.00127	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—UROD—head and neck cancer	7.35e-05	0.00127	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	7.33e-05	0.00127	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—HRAS—head and neck cancer	7.21e-05	0.00125	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.18e-05	0.00124	CbGpPWpGaD
Carbamazepine—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	7.17e-05	0.00124	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	7.14e-05	0.00124	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—NAT2—head and neck cancer	7.13e-05	0.00123	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—VEGFA—head and neck cancer	7.12e-05	0.00123	CbGpPWpGaD
Carbamazepine—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	7.07e-05	0.00122	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—STAT3—head and neck cancer	7.05e-05	0.00122	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	7.03e-05	0.00122	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	7.03e-05	0.00122	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	7.03e-05	0.00122	CbGpPWpGaD
Carbamazepine—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	6.8e-05	0.00118	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—MAPK3—head and neck cancer	6.73e-05	0.00117	CbGpPWpGaD
Carbamazepine—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	6.7e-05	0.00116	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—HRAS—head and neck cancer	6.62e-05	0.00115	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—UROD—head and neck cancer	6.56e-05	0.00114	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—VEGFA—head and neck cancer	6.54e-05	0.00113	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—STAT3—head and neck cancer	6.48e-05	0.00112	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—MAPK1—head and neck cancer	6.41e-05	0.00111	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—EGFR—head and neck cancer	6.41e-05	0.00111	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—UROD—head and neck cancer	6.4e-05	0.00111	CbGpPWpGaD
Carbamazepine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	6.35e-05	0.0011	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—DPYD—head and neck cancer	6.25e-05	0.00108	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—VEGFA—head and neck cancer	6.21e-05	0.00108	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—MAPK3—head and neck cancer	6.19e-05	0.00107	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—NOTCH1—head and neck cancer	6.14e-05	0.00106	CbGpPWpGaD
Carbamazepine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	6.13e-05	0.00106	CbGpPWpGaD
Carbamazepine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	6.04e-05	0.00105	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—UROD—head and neck cancer	5.98e-05	0.00104	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—YAP1—head and neck cancer	5.93e-05	0.00103	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—MAPK1—head and neck cancer	5.89e-05	0.00102	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—EGFR—head and neck cancer	5.89e-05	0.00102	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—MAPK3—head and neck cancer	5.88e-05	0.00102	CbGpPWpGaD
Carbamazepine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	5.81e-05	0.00101	CbGpPWpGaD
Carbamazepine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	5.73e-05	0.000992	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.7e-05	0.000987	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	5.65e-05	0.000978	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—MAPK1—head and neck cancer	5.59e-05	0.000969	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—EGFR—head and neck cancer	5.59e-05	0.000969	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—HRAS—head and neck cancer	5.14e-05	0.000891	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—UROD—head and neck cancer	5.11e-05	0.000885	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.09e-05	0.000881	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	4.88e-05	0.000845	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—NAT2—head and neck cancer	4.87e-05	0.000844	CbGpPWpGaD
Carbamazepine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	4.73e-05	0.000819	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—HRAS—head and neck cancer	4.73e-05	0.000819	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	4.68e-05	0.000811	CbGpPWpGaD
Carbamazepine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	4.66e-05	0.000808	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.64e-05	0.000803	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—AKT1—head and neck cancer	4.54e-05	0.000787	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—HRAS—head and neck cancer	4.49e-05	0.000778	CbGpPWpGaD
Carbamazepine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	4.48e-05	0.000776	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—VEGFA—head and neck cancer	4.43e-05	0.000768	CbGpPWpGaD
Carbamazepine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	4.42e-05	0.000766	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—STAT3—head and neck cancer	4.39e-05	0.000761	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—DPYD—head and neck cancer	4.27e-05	0.00074	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IL2—head and neck cancer	4.23e-05	0.000732	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—MAPK3—head and neck cancer	4.19e-05	0.000727	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	4.19e-05	0.000726	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—AKT1—head and neck cancer	4.17e-05	0.000723	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CCND1—head and neck cancer	4.12e-05	0.000713	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—YAP1—head and neck cancer	4.05e-05	0.000702	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—MAPK1—head and neck cancer	3.99e-05	0.000691	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—EGFR—head and neck cancer	3.99e-05	0.000691	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	3.98e-05	0.000689	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PTEN—head and neck cancer	3.98e-05	0.000689	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.96e-05	0.000687	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—UROD—head and neck cancer	3.94e-05	0.000683	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NAT2—head and neck cancer	3.6e-05	0.000624	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.6e-05	0.000623	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—VEGFA—head and neck cancer	3.59e-05	0.000622	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—TYMS—head and neck cancer	3.56e-05	0.000617	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—STAT3—head and neck cancer	3.56e-05	0.000616	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NAT2—head and neck cancer	3.52e-05	0.00061	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—GSTM1—head and neck cancer	3.52e-05	0.00061	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.47e-05	0.000601	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MAPK3—head and neck cancer	3.4e-05	0.000588	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—GPX1—head and neck cancer	3.37e-05	0.000584	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—CYP1A1—head and neck cancer	3.34e-05	0.000578	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.24e-05	0.000561	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MAPK1—head and neck cancer	3.23e-05	0.00056	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—EGFR—head and neck cancer	3.23e-05	0.00056	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.21e-05	0.000556	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—HRAS—head and neck cancer	3.2e-05	0.000555	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—DPYD—head and neck cancer	3.16e-05	0.000547	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.13e-05	0.000543	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—DPYD—head and neck cancer	3.09e-05	0.000535	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NAT2—head and neck cancer	3.05e-05	0.000528	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—YAP1—head and neck cancer	3e-05	0.000519	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.96e-05	0.000514	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—YAP1—head and neck cancer	2.93e-05	0.000508	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.89e-05	0.000501	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.86e-05	0.000496	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—AKT1—head and neck cancer	2.83e-05	0.00049	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.82e-05	0.000489	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.82e-05	0.000489	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PIK3CA—head and neck cancer	2.8e-05	0.000486	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NAT2—head and neck cancer	2.72e-05	0.000472	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—head and neck cancer	2.71e-05	0.00047	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—DPYD—head and neck cancer	2.67e-05	0.000463	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NAT2—head and neck cancer	2.66e-05	0.00046	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.64e-05	0.000457	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.61e-05	0.000452	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HRAS—head and neck cancer	2.59e-05	0.000449	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—YAP1—head and neck cancer	2.54e-05	0.00044	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NAT2—head and neck cancer	2.48e-05	0.00043	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.45e-05	0.000424	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—TYMS—head and neck cancer	2.43e-05	0.000422	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GSTM1—head and neck cancer	2.41e-05	0.000417	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—DPYD—head and neck cancer	2.39e-05	0.000414	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.37e-05	0.00041	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—DPYD—head and neck cancer	2.33e-05	0.000404	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GPX1—head and neck cancer	2.3e-05	0.000399	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—AKT1—head and neck cancer	2.29e-05	0.000397	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CYP1A1—head and neck cancer	2.28e-05	0.000395	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—YAP1—head and neck cancer	2.27e-05	0.000392	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.25e-05	0.00039	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.23e-05	0.000386	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—YAP1—head and neck cancer	2.21e-05	0.000383	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—DPYD—head and neck cancer	2.18e-05	0.000377	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NAT2—head and neck cancer	2.12e-05	0.000367	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—YAP1—head and neck cancer	2.07e-05	0.000358	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2e-05	0.000346	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTGS2—head and neck cancer	1.99e-05	0.000344	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.91e-05	0.00033	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—DPYD—head and neck cancer	1.86e-05	0.000322	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—TYMS—head and neck cancer	1.8e-05	0.000312	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTM1—head and neck cancer	1.78e-05	0.000308	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—YAP1—head and neck cancer	1.77e-05	0.000306	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—TYMS—head and neck cancer	1.76e-05	0.000305	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.74e-05	0.000301	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTEN—head and neck cancer	1.73e-05	0.0003	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GPX1—head and neck cancer	1.7e-05	0.000295	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.7e-05	0.000295	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	1.69e-05	0.000292	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GPX1—head and neck cancer	1.67e-05	0.000289	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.66e-05	0.000288	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP1A1—head and neck cancer	1.65e-05	0.000286	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NAT2—head and neck cancer	1.64e-05	0.000284	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.55e-05	0.000269	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—TYMS—head and neck cancer	1.52e-05	0.000264	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.51e-05	0.000261	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.48e-05	0.000257	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GPX1—head and neck cancer	1.44e-05	0.00025	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—DPYD—head and neck cancer	1.44e-05	0.000249	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.43e-05	0.000247	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—YAP1—head and neck cancer	1.36e-05	0.000236	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—TYMS—head and neck cancer	1.36e-05	0.000236	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS2—head and neck cancer	1.36e-05	0.000235	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.35e-05	0.000234	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.34e-05	0.000233	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—TYMS—head and neck cancer	1.33e-05	0.00023	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.33e-05	0.00023	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTM1—head and neck cancer	1.31e-05	0.000227	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GPX1—head and neck cancer	1.29e-05	0.000223	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.27e-05	0.000221	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GPX1—head and neck cancer	1.26e-05	0.000218	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.24e-05	0.000216	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—TYMS—head and neck cancer	1.24e-05	0.000215	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.23e-05	0.000212	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CA—head and neck cancer	1.22e-05	0.000212	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTEN—head and neck cancer	1.18e-05	0.000205	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GPX1—head and neck cancer	1.17e-05	0.000203	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.17e-05	0.000203	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.16e-05	0.000201	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.16e-05	0.0002	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—TYMS—head and neck cancer	1.06e-05	0.000184	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.05e-05	0.000181	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.05e-05	0.000181	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GPX1—head and neck cancer	1e-05	0.000174	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS2—head and neck cancer	1e-05	0.000174	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—AKT1—head and neck cancer	9.98e-06	0.000173	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	9.93e-06	0.000172	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS2—head and neck cancer	9.81e-06	0.00017	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.55e-06	0.000165	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTEN—head and neck cancer	8.75e-06	0.000152	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTEN—head and neck cancer	8.55e-06	0.000148	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS2—head and neck cancer	8.49e-06	0.000147	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CA—head and neck cancer	8.35e-06	0.000145	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—TYMS—head and neck cancer	8.18e-06	0.000142	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.16e-06	0.000141	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTM1—head and neck cancer	8.09e-06	0.00014	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GPX1—head and neck cancer	7.74e-06	0.000134	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	7.67e-06	0.000133	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS2—head and neck cancer	7.58e-06	0.000131	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTEN—head and neck cancer	7.41e-06	0.000128	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS2—head and neck cancer	7.4e-06	0.000128	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS2—head and neck cancer	6.91e-06	0.00012	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—AKT1—head and neck cancer	6.82e-06	0.000118	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTEN—head and neck cancer	6.61e-06	0.000115	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTEN—head and neck cancer	6.45e-06	0.000112	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	6.17e-06	0.000107	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	6.03e-06	0.000105	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTEN—head and neck cancer	6.03e-06	0.000104	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS2—head and neck cancer	5.91e-06	0.000102	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CA—head and neck cancer	5.23e-06	9.05e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTEN—head and neck cancer	5.15e-06	8.92e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AKT1—head and neck cancer	5.04e-06	8.73e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AKT1—head and neck cancer	4.93e-06	8.54e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	4.66e-06	8.08e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.56e-06	7.9e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CA—head and neck cancer	4.55e-06	7.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AKT1—head and neck cancer	4.27e-06	7.39e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	4.25e-06	7.37e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTEN—head and neck cancer	3.98e-06	6.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AKT1—head and neck cancer	3.81e-06	6.6e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AKT1—head and neck cancer	3.72e-06	6.44e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.63e-06	6.3e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AKT1—head and neck cancer	3.47e-06	6.02e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKT1—head and neck cancer	2.97e-06	5.14e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.8e-06	4.86e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKT1—head and neck cancer	2.29e-06	3.97e-05	CbGpPWpGaD
